gvtcx

National Procurement for HIV and Preventative Treatments

NHS England Published 8 Mar 2022 Find a Tender
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Statuscomplete
Category (CPV) 33600000 +1 more
RegionYorkshire and the Humber
Procedureselective
OCIDocds-h6vhtk-02beca

Awards (15)

This procurement was awarded to 15 suppliers. Values shown are per-award; the notice total is ·.

SupplierValueDateStatus
Abbvie Ltd shared · · active
Amarox Limited shared · · active
Dr.Reddy's Laboratories (UK) Limited shared · · active
Gilead Sciences Limited shared · · active
Glenmark Pharmaceuticals Europe Limited shared · · active
Janssen-Cilag Ltd shared · · active
Lupin Healthcare (UK) Limited shared · · active
Macleods Pharma UK Limited shared · · active
Mawdsley-Brooks and Co Ltd shared · · active
Merck Sharpe and Dohme (UK) Limited shared · · active
Mylan shared · · active
Teva UK Limited shared · · active
Tillomed Laboratories ltd shared · · active
ViiV Healthcare shared · · active
Zentiva Pharma UK Ltd shared · · active

description

National Procurement for HIV and Preventative Treatments

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
22 Jun 2021 Prior information notice (F01) Earlier regulations 014167-2021
8 Mar 2022 Contract award notice (F03) Earlier regulations 006329-2022

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.